Trinity Biotech PLC
NASDAQ:TRIB
Trinity Biotech PLC
Net Income (Common)
Trinity Biotech PLC
Net Income (Common) Peer Comparison
Competitive Net Income (Common) Analysis
Latest Figures & CAGR of Competitors
Company | Net Income (Common) | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Trinity Biotech PLC
NASDAQ:TRIB
|
Net Income (Common)
-$24m
|
CAGR 3-Years
-55%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
N/A
|
|
Medtronic PLC
NYSE:MDT
|
Net Income (Common)
$4.2B
|
CAGR 3-Years
13%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
2%
|
|
STERIS plc
NYSE:STE
|
Net Income (Common)
$566.8m
|
CAGR 3-Years
9%
|
CAGR 5-Years
16%
|
CAGR 10-Years
16%
|
See Also
What is Trinity Biotech PLC's Net Income (Common)?
Net Income (Common)
-24m
USD
Based on the financial report for Dec 31, 2023, Trinity Biotech PLC's Net Income (Common) amounts to -24m USD.
What is Trinity Biotech PLC's Net Income (Common) growth rate?
Net Income (Common) CAGR 5Y
-2%
Over the last year, the Net Income (Common) growth was 41%. The average annual Net Income (Common) growth rates for Trinity Biotech PLC have been -55% over the past three years , -2% over the past five years .